Can Nutex Health Stock Recover If Markets Fall?
Nutex Health (NUTX) stock is down 11.8% in 5 trading days. The recent slide reflects renewed concerns around its reliance on out-of-network reimbursement via the IDR process and past accounting restatements, but sharp drops like this often raise a tougher question: is the weakness temporary, or a sign of deeper cracks in the story?
Before judging its downturn reslience, let’s look at where Nutex Health stands today.
- Size: Nutex Health is a $993 Mil company with $981 Mil in revenue currently trading at $148.19.
- Fundamentals: Last 12 month revenue growth of 236.0% and operating margin of 36.6%.
- Liquidity: Has Debt to Equity ratio of 0.36 and Cash to Assets ratio of 0.17
- Valuation: Nutex Health stock is currently trading at P/E multiple of 8.2 and P/EBIT multiple of 2.8
- Has returned (median) 7.7% within a year following sharp dips since 2010. See NUTX Dip Buy Analysis.
These metrics point to a Strong operational performance, alongside Low valuation – making the stock Attractive. For details, see Buy or Sell NUTX Stock
That brings us to the key consideration for investors worried about this fall: how resilient is NUTX stock if markets turn south? This is where our downturn resilience framework comes in. Suppose NUTX stock falls another 20-30% to $104 – can investors comfortably hold on? Turns out, the stock has fared worse than the S&P 500 index during various economic downturns, based on (a) how much the stock fell and, (b) how quickly it recovered. Below, we dive deeper into each such downturn.
- How To Earn 9.2% Yield While Waiting to Buy LLY 30% Cheaper
- Could Accenture Stock’s Cash Flow Spark the Next Rally?
- Years of Rewards: $35 Bil From Charter Communications Stock
- McDonald’s Stock Capital Return Hits $35 Bil
- Palo Alto Networks Stock at Support Zone – Bargain or Trap?
- Super Micro Computer Stock Pulls Back to Support – Smart Entry?
2022 Inflation Shock
- NUTX stock fell 99.6% from a high of $6,000.00 on 4 April 2022 to $26.25 on 18 December 2023 vs. a peak-to-trough decline of 25.4% for the S&P 500.
- The stock is yet to recover to its pre-Crisis high
- The highest the stock has reached since then is $190.49 on 11 December 2025 , and currently trades at $148.19
| NUTX | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -99.6% | -25.4% |
| Time to Full Recovery | Not Fully Recovered | 464 days |
2020 Covid Pandemic
- NUTX stock fell 49.1% from a high of $412.50 on 17 March 2020 to $210.00 on 23 March 2020 vs. a peak-to-trough decline of 33.9% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 4 April 2022
| NUTX | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -49.1% | -33.9% |
| Time to Full Recovery | 742 days | 148 days |
2018 Correction
- NUTX stock fell 97.0% from a high of $10.50 on 16 March 2018 to $0.32 on 28 October 2019 vs. a peak-to-trough decline of 19.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 1 November 2019
| NUTX | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -97.0% | -19.8% |
| Time to Full Recovery | 4 days | 120 days |
Feeling jittery about NUTX stock? Consider portfolio approach.
Multi Asset Portfolios Offer More Upside With Less Risk
Individual picks are volatile but diversified assets offset each other. A multi asset portfolio helps you stay the course capture upside and reduce downside.
The asset allocation framework of Trefis’ Boston-based, wealth management partner yielded positive returns during the 2008-09 period when the S&P lost more than 40%. Our partner’ strategy now includes Trefis High Quality Portfolio, which has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices